Drug Pipeline

Clemastine Fumarate Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 2
1
Phase 1/2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT02521311 Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis… Optic Neuritis Recruiting
Phase 1/2
NCT05359653 Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a… Multiple Sclerosis (MS) Recruiting
NCT06065670 Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions… Demyelinating Diseases Not Yet Recruiting
Sponsors Running Clemastine Fumarate Trials
University of California, San Francisco (3)
Disease Areas
Multiple Sclerosis (2)
Get alerts when Clemastine Fumarate trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free